FORMULATION AND OPTIMIZATION OF NANOSUSPENSION FOR IMPROVING SOLUBILITY AND DISSOLUTION OF GEMFIBROZIL
Objective: The study aims at the formulation and optimization of gemfibrozil (Gem) nanosuspension (NS) for improving its solubility and dissolution rate.
Method: Gem NS was prepared by precipitation-ultrasonication method using ethanol as solvent, water as anti-solvent, and polyvinyl alcohol (PVA) as a stabilizer. A Boxâ€“Behnken design was employed to study the effect of the independent variables, Gem concentration in the organic phase (X1), PVA concentration (X2) and sonication time (X3) on the dependent variable, drug release after 90 min (Y). The resulting data were statistically analyzed and subjected to 3D response surface methodology to study the influence of variables on the response. NS was evaluated for particle size, zeta potential, solubility and in vitro drug release and characterized using Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and X-ray diffractometry (XRD).
Results: On the basis of the evaluation, NS4 formulation (with 80 mg/ml Gem, 0.5% PVA concentration, and 20 min of sonication time) demonstrated highest drug content with a particle size of 191.0 nm and zeta potential of âˆ’12.0 mV. Dissolution profiles of NS indicated 2.5-fold increase in drug release than pure drug. NS demonstrated 5- and 9-fold increase in solubility, in water, and phosphate buffer (pH 7.5), respectively, pure drug. DSC and XRD studies indicated changes in the crystallinity of Gem during NS formulation. No chemical change was evident in NS as indicated by FTIR.
Conclusion: Gem NS formulation could serve as a promising approach for improving its solubility and dissolution rate.
2. Raju A, Reddy AJ, Satheesh J, Jithan AV. Preparation and characterisation of nevirapine oral nanosuspensions. Indian J Pharm Sci 2014;76:62-71.
3. Thadkala K, Sailu C, Aukunuru J. Formulation, optimization and evaluation of oral nanosuspension tablets of nebivolol hydrochloride for enhancement of dissoluton rate. Der Pharm Lett 2015;7:71-84.
4. Khadka P, Ro J, Kim H, Kim I, Kim J, Kim H. Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 2014;9:304-16.
5. Khan A, Iqbal Z, Shah Y, Ahmad L, Ismail, Ullah Z, et al. Enhancement of dissolution rate of class II drugs (Hydrochlorothiazide); A comparative study of the two novel approaches; solid dispersion and liqui-solid techniques. Saudi Pharm J 2015;23:650-7.
6. Krishna K, Kumar G. Nanosuspensions: The solution to deliver hydrophobic drugs. Int J Drug Deliv 2011;3:546-57.
7. Kavitha V, Neethu C, Dineshkumar B, Krishnakumar K, John A. Nanosuspension formulation : An improved drug delivery system. Nanosci Nanotechnol Int J 2014;4:1-5.
8. Singare D, Marella S, Gowthamrajan K, Kulkarni G, Vooturi R, Rao P. Optimization of formulation and process variable of nanosuspension: An industrial perspective. Int J Pharm 2010;402:213-20.
9. Lakshmi P, Kumar G. Nanosuspension technology : A review. Int J Pharm Pharm Sci 2010;2:35-40.
10. Geetha G, Poojitha U, Arshad K, Khan A. Various techniques for preparation of nanosuspension-a review. Int J Pharm Res Rev 2014;3:30-7.
11. Sinha B, Muller R, Muschwitzer J. Bottom-up approaches for preparing drug nanocrystals: Formulations and factors affecting particle size. Int J Pharm 2013;453:126-41.
12. Bhalekar M, Upadhaya P, Reddy S, Kshirsagar S, Madgulkar A. Formulation and evaluation of acyclovir nanosuspension for enhancement of oral bioavailability. Asian J Pharm 2014;8:110-8.
13. Yang J, Young A, Chiang P, Thurston A, Pretzer D. Fluticasone and budesonide nanosuspensions for pulmonary delivery: Preparation, characterization, and pharmacokinetic studies. J Pharm Sci 2008;97:4869-78.
14. Sun W, Mao S, Shi Y, Li L, Fang L. Nanonization of itraconazole by high pressure homogenization: Stabilizer optimization and effect of particle size on oral absorption. J Pharm Sci 2011;100:3365-73.
15. Chattopadhyay P, Gupta R. Production of griseofulvin nanoparticles using supercritical CO2 anti solvent with enhanced mass transfer. Int J Pharm 2001;228:19-31.
16. Pignatello R, Ricupero N, Bucolo C, Maugeri F, Maltese A, Puglisi G, et al. Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene. AAPS PharmSciTech 2006;7:E27.
17. Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci 2010;40:325-34.
18. Pandya V, Patel J, Patel D. Formulation, optimization and characterization of simvastatin nanosuspension prepared by nanoprecipitation technique. Der Pharm Lett 2011;3:129-40.
19. Liu D, Xu H, Tian B, Yuan K, Pan H, Ma S. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitationâ€“ultrasonication method for the improvement of dissolution rate and oral bioavailability. AAPS PharmSciTech 2012;13:295-304.
20. Salem HF, Kharshoum RM. Nanoprecipitation technique for preparation of sterically stabilized risperidone nanosuspension: In vitro and in vivo study. Int J Pharm Pharm Sci 2016;8:136-42.
21. Taneja S, Shilpi S, Khatri K. Formulation and optimization of efavirenz nanosuspensions using the precipitation-ultrasonication technique for solubility enhancement. Artif Cells Nanomed Biotechnol 2016;44:978 84.
22. Patel R, Baviskar T, Rajput A. Development and in-vivo characterization of SMEDDs (self-microemulsifying drug delivery system) for gemfibrozil. Int J Pharm Pharm Sci 2013;5:793-800.
23. Talib H, Watersa L, Gareth M, Parkes G. Microwave processed solid dispersions for enhanced dissolution ofgemfibrozil using non-ordered mesoporous silica. Colloids Surf A Physicochem Eng Asp 2017;520:428-35.
24. Huang QP, Wang JX, Chen GZ, Shen ZG, Chen JF, Yun J. Micronization of gemfibrozil by reactive precipitation process. Int J Pharm 2008;360:58-64.
25. Villar AM, Naveros BC, Campmany AC, Trenchs MA, Rocabert CB, Bellowa LH. Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int J Pharm 2012;431:161-75.
26. Prakash S, Vidyadhara S, Sasidhar RL, Abhijit D, Akhilesh D. Development and characterization of ritonavir nanosuspension for oral use. Der Pharm Lett 2013;5:48-55.
27. Agarwal V, Bajpai M. Preparation and optimization of esomeprazole nanosuspension using evaporative precipitation-ultrasonication. Trop J Pharm Res 2014;13:497-503.
28. Das S, Suresh PK. Nanosuspension: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B. Nanomedicine 2011;7:242-7.
29. Mishra B, Sahoo J, Dixit P. Formulation and process optimization of naproxen nanosuspensions stabilized by hydroxy propyl methyl cellulose. Carbohydr Polym 2015;127:300-8.
30. He W, Lu Y, Qi J, Chen L, Yin L, Wu W. Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: Physical characterization, redispersibility, and dissolution. Int J Nanomedicine 2013;8:3119-28.
31. Kayser O. Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against Leishmania infected macrophages. Int J Pharm 2000;196:253-6.
32. Gubbala LP, Arutla S, Venkateshwarlu V. Preparation and solid
state characterization of nanocrystals for solubility enhancement of Quetiapine fumarate. Int J Pharm Pharm Sci 2014;6:358-64.
33. Seenivasan P, Haritha P, Maheswara U, Reddy C. An approach for the improvement of dissolution rate of Aceclofenac. Res J Pharm Biol Chem Sci 2013;4:1064-71.
34. Bajaj A, Rao M, Pardeshi A, Sali D. Nanocrystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan. AAPS PharmSciTech 2012;13:1331-40.